GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmiva AB (OSTO:PHARM) » Definitions » YoY EBITDA Growth

Pharmiva AB (OSTO:PHARM) YoY EBITDA Growth : 62.02% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Pharmiva AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pharmiva AB's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 62.02%.

Pharmiva AB's EBITDA per Share for the three months ended in Jun. 2023 was kr-0.33.


Pharmiva AB YoY EBITDA Growth Historical Data

The historical data trend for Pharmiva AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmiva AB YoY EBITDA Growth Chart

Pharmiva AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
- -48.56 -79.70 56.89

Pharmiva AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.31 29.21 57.58 65.24 62.02

Pharmiva AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pharmiva AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-1.282--2.974)/ | -2.974 |
=56.89 %

Pharmiva AB's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(-0.327--0.861)/ | -0.861 |
=62.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmiva AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pharmiva AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmiva AB (OSTO:PHARM) Business Description

Traded in Other Exchanges
N/A
Address
Sankt Lars Väg 45B, Lund, SWE, 222 70
Pharmiva AB is a medical technology company. It develops innovative antibiotic-free medical products in order to improve vaginal health.

Pharmiva AB (OSTO:PHARM) Headlines

No Headlines